ID   SRBS2_RAT               Reviewed;        1196 AA.
AC   O35413; Q923T8;
DT   22-JUL-2008, integrated into UniProtKB/Swiss-Prot.
DT   22-JUL-2008, sequence version 2.
DT   24-JUL-2024, entry version 144.
DE   RecName: Full=Sorbin and SH3 domain-containing protein 2;
DE   AltName: Full=Arg-binding protein 2;
DE            Short=ArgBP2;
DE   AltName: Full=Arg/Abl-interacting protein 2;
DE   AltName: Full=Neural ArgBP2;
DE            Short=nArgBP2;
DE   AltName: Full=Sorbin;
GN   Name=Sorbs2; Synonyms=Argbp2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INTERACTION WITH SAPAP; VCL AND
RP   AFDN, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, AND FUNCTION.
RC   TISSUE=Brain;
RX   PubMed=10521485; DOI=10.1074/jbc.274.43.30914;
RA   Kawabe H., Hata Y., Takeuchi M., Ide N., Mizoguchi A., Takai Y.;
RT   "nArgBP2, a novel neural member of ponsin/ArgBP2/vinexin family that
RT   interacts with synapse-associated protein 90/postsynaptic density-95-
RT   associated protein (SAPAP).";
RL   J. Biol. Chem. 274:30914-30918(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 182-354 (ISOFORM 2), AND AMIDATION AT ALA-148
RP   (ISOFORM 2).
RC   STRAIN=Wistar;
RX   PubMed=11786189; DOI=10.1016/s0196-9781(01)00558-7;
RA   Wahbi K., Magaud J.-P., Pansu D., Descroix-Vagne M.;
RT   "Coding region of the sorbin gene in different species.";
RL   Peptides 22:2045-2053(2001).
RN   [3]
RP   INTERACTION WITH FLOT1; PTK2B AND CBL, AND SUBCELLULAR LOCATION.
RX   PubMed=15128873; DOI=10.1242/jcs.01148;
RA   Haglund K., Ivankovic-Dikic I., Shimokawa N., Kruh G.D., Dikic I.;
RT   "Recruitment of Pyk2 and Cbl to lipid rafts mediates signals important for
RT   actin reorganization in growing neurites.";
RL   J. Cell Sci. 117:2557-2568(2004).
RN   [4]
RP   SUBCELLULAR LOCATION.
RX   PubMed=16125169; DOI=10.1016/j.yexcr.2005.06.026;
RA   Roenty M., Taivainen A., Moza M., Kruh G.D., Ehler E., Carpen O.;
RT   "Involvement of palladin and alpha-actinin in targeting of the Abl/Arg
RT   kinase adaptor ArgBP2 to the actin cytoskeleton.";
RL   Exp. Cell Res. 310:88-98(2005).
RN   [5]
RP   TISSUE SPECIFICITY, SUBCELLULAR LOCATION, AND INTERACTION WITH SYNJ1;
RP   SYNJ2; DNM1; DNM2; VCL; WASF; CBL; ABL; SPTAN1 AND PTK2B.
RX   PubMed=15659545; DOI=10.1073/pnas.0409376102;
RA   Cestra G., Toomre D., Chang S., De Camilli P.;
RT   "The Abl/Arg substrate ArgBP2/nArgBP2 coordinates the function of multiple
RT   regulatory mechanisms converging on the actin cytoskeleton.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:1731-1736(2005).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27; SER-40; SER-143; SER-254;
RP   SER-343; SER-354; SER-397; SER-589; SER-645; SER-648; SER-844 AND SER-1113,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Adapter protein that plays a role in the assembling of
CC       signaling complexes, being a link between ABL kinases and actin
CC       cytoskeleton. Can form complex with ABL1 and CBL, thus promoting
CC       ubiquitination and degradation of ABL1 (By similarity). May play a role
CC       in the regulation of pancreatic cell adhesion, possibly by acting on
CC       WASF1 phosphorylation, enhancing phosphorylation by ABL1, as well as
CC       dephosphorylation by PTPN12 (By similarity). Isoform 2 increases water
CC       and sodium absorption in the intestine and gall-bladder. {ECO:0000250,
CC       ECO:0000250|UniProtKB:O94875, ECO:0000269|PubMed:10521485}.
CC   -!- SUBUNIT: Interacts with ABL1/c-Abl, ABL2/v-Abl/Arg, ACTN, CBL and PALLD
CC       (By similarity). Interacts with ABL, CBL, DNM1, DNM2, FLOT1, AFDN,
CC       PTK2B/PYK2, SAPAP, SPTAN1, SYNJ1, SYNJ2, VCL/vinculin and WASF.
CC       Interacts with PTPN12 and WASF1 via its SH3 domains; this interaction
CC       may mediate the partial PTPN12 and WASF1 translocation to focal
CC       adhesion sites. {ECO:0000250, ECO:0000250|UniProtKB:O94875,
CC       ECO:0000269|PubMed:10521485, ECO:0000269|PubMed:15128873,
CC       ECO:0000269|PubMed:15659545}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, perinuclear region
CC       {ECO:0000269|PubMed:10521485, ECO:0000269|PubMed:15128873,
CC       ECO:0000269|PubMed:15659545, ECO:0000269|PubMed:16125169}. Apical cell
CC       membrane {ECO:0000250|UniProtKB:O94875}. Cell junction, focal adhesion
CC       {ECO:0000250|UniProtKB:O94875}. Cell projection, lamellipodium
CC       {ECO:0000250|UniProtKB:O94875}. Note=Detected in the stress fibers,
CC       synaptosomal cytosol, postsynaptic density fraction, Z-disks and
CC       intercalated. The CBL/PTK2B/ARGBP2 complex is recruited to lipid rafts
CC       following growth factor stimulation. In pancreatic acinar cells,
CC       localized preferentially to the apical membrane. Colocalized with
CC       vinculin and filamentous actin at focal adhesions and lamellipodia of
CC       pancreatic cells. {ECO:0000250|UniProtKB:O94875}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O35413-1; Sequence=Displayed;
CC       Name=2; Synonyms=Sorbin;
CC         IsoId=O35413-2; Sequence=VSP_034812, VSP_034813, VSP_034814,
CC                                  VSP_034815;
CC   -!- TISSUE SPECIFICITY: Expressed in brain; found in synapses in
CC       cerebellum. {ECO:0000269|PubMed:10521485, ECO:0000269|PubMed:15659545}.
CC   -!- DOMAIN: The first 2 SH3 domains are required for WASF1-binding. All 3
CC       SH3 domains can bind independently to PTPN12.
CC       {ECO:0000250|UniProtKB:O94875}.
CC   -!- PTM: Ubiquitinated by CBL. {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF026505; AAB81527.1; -; mRNA.
DR   EMBL; AF396458; AAK81861.1; -; mRNA.
DR   PIR; T14108; T14108.
DR   RefSeq; NP_446222.1; NM_053770.1.
DR   AlphaFoldDB; O35413; -.
DR   SMR; O35413; -.
DR   BioGRID; 250427; 9.
DR   IntAct; O35413; 3.
DR   MINT; O35413; -.
DR   STRING; 10116.ENSRNOP00000029182; -.
DR   iPTMnet; O35413; -.
DR   PhosphoSitePlus; O35413; -.
DR   PaxDb; 10116-ENSRNOP00000029182; -.
DR   GeneID; 114901; -.
DR   KEGG; rno:114901; -.
DR   AGR; RGD:620061; -.
DR   CTD; 8470; -.
DR   RGD; 620061; Sorbs2.
DR   eggNOG; KOG4225; Eukaryota.
DR   InParanoid; O35413; -.
DR   OrthoDB; 5407056at2759; -.
DR   PhylomeDB; O35413; -.
DR   Reactome; R-RNO-264870; Caspase-mediated cleavage of cytoskeletal proteins.
DR   Reactome; R-RNO-6794361; Neurexins and neuroligins.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   PRO; PR:O35413; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0005925; C:focal adhesion; IEA:UniProtKB-SubCell.
DR   GO; GO:0030027; C:lamellipodium; IEA:UniProtKB-SubCell.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; ISO:RGD.
DR   GO; GO:0095500; P:acetylcholine receptor signaling pathway; ISO:RGD.
DR   GO; GO:0061049; P:cell growth involved in cardiac muscle cell development; IGI:BHF-UCL.
DR   GO; GO:0007219; P:Notch signaling pathway; ISO:RGD.
DR   GO; GO:1904393; P:regulation of skeletal muscle acetylcholine-gated channel clustering; ISO:RGD.
DR   CDD; cd11920; SH3_Sorbs2_1; 1.
DR   CDD; cd11923; SH3_Sorbs2_2; 1.
DR   CDD; cd11917; SH3_Sorbs2_3; 1.
DR   Gene3D; 2.30.30.40; SH3 Domains; 3.
DR   InterPro; IPR050384; Endophilin_SH3RF.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR003127; SoHo_dom.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   PANTHER; PTHR14167:SF56; DREBRIN-LIKE PROTEIN-RELATED; 1.
DR   PANTHER; PTHR14167; SH3 DOMAIN-CONTAINING; 1.
DR   Pfam; PF00018; SH3_1; 2.
DR   Pfam; PF14604; SH3_9; 1.
DR   Pfam; PF02208; Sorb; 1.
DR   PRINTS; PR00499; P67PHOX.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00326; SH3; 3.
DR   SMART; SM00459; Sorb; 1.
DR   SUPFAM; SSF50044; SH3-domain; 3.
DR   PROSITE; PS50002; SH3; 3.
DR   PROSITE; PS50831; SOHO; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Amidation; Cell junction; Cell membrane;
KW   Cell projection; Cytoplasm; Membrane; Phosphoprotein; Reference proteome;
KW   Repeat; SH3 domain; Ubl conjugation.
FT   CHAIN           1..1196
FT                   /note="Sorbin and SH3 domain-containing protein 2"
FT                   /id="PRO_0000344479"
FT   DOMAIN          166..227
FT                   /note="SoHo"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00195"
FT   DOMAIN          959..1018
FT                   /note="SH3 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          1034..1095
FT                   /note="SH3 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   DOMAIN          1137..1196
FT                   /note="SH3 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   REGION          25..57
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          75..95
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          235..314
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          329..407
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          929..958
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        42..57
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        77..95
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        235..261
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        278..308
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        366..403
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        929..945
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         27
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         28
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UTJ2"
FT   MOD_RES         40
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         130
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UTJ2"
FT   MOD_RES         143
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         254
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         334
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O94875"
FT   MOD_RES         340
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UTJ2"
FT   MOD_RES         343
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         354
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         372
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O94875"
FT   MOD_RES         382
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O94875"
FT   MOD_RES         387
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O94875"
FT   MOD_RES         392
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UTJ2"
FT   MOD_RES         393
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O94875"
FT   MOD_RES         394
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O94875"
FT   MOD_RES         396
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O94875"
FT   MOD_RES         397
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         399
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O94875"
FT   MOD_RES         478
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UTJ2"
FT   MOD_RES         589
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         592
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q3UTJ2"
FT   MOD_RES         645
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         648
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         844
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         938
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O94875"
FT   MOD_RES         1113
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1119
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O94875"
FT   VAR_SEQ         1..181
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11786189"
FT                   /id="VSP_034812"
FT   VAR_SEQ         182..185
FT                   /note="GIPT -> MISQ (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11786189"
FT                   /id="VSP_034813"
FT   VAR_SEQ         326..334
FT                   /note="VYQSSIDRS -> KPQAGRRKV (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11786189"
FT                   /id="VSP_034814"
FT   VAR_SEQ         335..1196
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11786189"
FT                   /id="VSP_034815"
FT   CONFLICT        265
FT                   /note="T -> P (in Ref. 1; AAB81527)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        354
FT                   /note="S -> V (in Ref. 2; AAK81861)"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         O35413-2:148
FT                   /note="Alanine amide"
FT                   /evidence="ECO:0000269|PubMed:11786189"
SQ   SEQUENCE   1196 AA;  134057 MW;  122E5B7B0534B855 CRC64;
     MNTDSGGCAR KRAAMSVTLT SVKRVQSSPN LLAAGRESHS PDSAWRSYNG RNPETLNGDA
     TYSSLAAKGF RSVRPNLQDK KSPTQSHITI NGNSGGAVSP VSYYQRPFSP SAYSLPASLN
     SSIIMPHGRS LDSAETYSQH AQSLDGTMGS SIPLYRSSEE EKRVTVIKAP HYPGIGPVDE
     SGIPTAIRTT VDRPKDWYKT MFKQIHMVHK PDEDTDMYNT PYTYNAGLYN SPYSAQSHPA
     AKTQTYRPLS KSHSDNGTDA FKEATSPVPP PHVPPRPRDQ SSTEKHDWDP PDRKVDTRKF
     RSEPRSIFEY EPGKSSILQH ERPVSVYQSS IDRSLERPSS SASMAGDFRK RRKSEPAVGP
     PRGLGDHSSS RTSPGRADLP GSSSTFTTSF ISSSPSSPSR AQGGDDSKMC PPLCSYSGLN
     GSPSSELECC GAYRRHLDVP QDSQRAITFK NGWQMARQNA EIWSSTEEAV SPKIKSRSCD
     DLLNDDCGSF PDPKTKSESM GSLLCDEGSK ESDPMTWTSP YIPEVCGNSR SRLKHRSAHN
     APGFLKMYKK MHRINRKDLM NSEVICSVKS RILQYEKEQQ HRGLLHGWSQ SSTEEVPRDV
     VPTRISEFEK LIQKSKSMPN LGDEMLSPVT LEPPQNGLCP KRRFSIESLL EEETQVRHPS
     QGQRSCKSNT LVPIHIEVTS DEQPRTHMEF SDSDQDGVVS DHSDNVHVER SSFCSESDFD
     HFSFTSSESF YGSSHHHHHH HHHHGHFISS CKGRCPASYT RFTTMLKHER AKHENIDRPR
     RQDMDPGLSK LAFLVSPVPF RRKKVLTPQK QTEQAKCKAS VVEALDSALK DICDQIKAEK
     RRGSLPDNSI LHRLISELLP QIPKRNSSLN ALKRSPMHQP FHPLPQDGAI HCPLYQNDCG
     RMPHSASFPD VDTTSSYHAQ DYGSVLSLQD HESPRSYSST LTDLGRSVSR ERRGTPEKEV
     KLPAKAVYDF KAQTSKELSF KKGDTVYILR KIDQNWYEGE HHGRVGIFPI SYVEKLTPPE
     KAQPARPPPP VQPGEIGEAI AKYNFNADTN VELSLRKGDR IILLKRVDQN WYEGKIPGTN
     RQGIFPVSYV EVVKRNTKGS EDYPDPPLPH SYSSDRIYSL SSNKPQRPVF SHENIQGGGE
     PFQALYNYTP RNEDELELRE SDVVDVMEKC DDGWFVGTSR RTKFFGTFPG NYVKRL
//
